Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients

Clinical trial NCT07342803 · RECRUITING

Trial details

NCT number: NCT07342803
Sponsor: Longbio Pharma
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Asthma

Start date: 2025-01-25
Primary completion: 2027-12-28
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.